Market News
Stay updated with the latest market trends, earnings, and economic indicators.
Caplin Steriles receives USFDA approval for Foscarnet Sodium Injection
Caplin Steriles (CSL), a subsidiary company of Caplin Point Laboratories has been granted final approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) Foscarnet Sodium Injection (6000 mg/250 mL Infusion Bag), a generic therapeutic equivalent version of the Reference Listed Drug (RLD) Foscavir Injection from Clinigen Healthcare, (NDA 020068).
Caplin Point shares surge over 9% after Q4 results — Profit up 19%; dividend declared
Caplin Point’s board also approved an interim dividend of ₹4 per equity share for FY26. The company has fixed May 30, 2026, as the record date for determining shareholder eligibility for the dividend.
Trade Spotlight: How should you trade Caplin Point, Max Health, Fortis Healthcare, Deepak Fertilisers, InterGlobe Aviation, and others on June 9?
Following the sharp sell-off, the market is expected to consolidate and trade in a range-bound manner. Below are some short-term trading ideas to consider.